Glaukos Corp. (6GJ)
FSX
Closed
Oct 23, 2026
Day's Range
155.0052 wk Range
63.50Overview - 6GJ - Glaukos Corp.
Key Statistics
Valuation
Enterprise Value
7.50B
P/E (Trailing)
-44.51
P/E (Forward)
-102.09
PEG Ratio
5.04
Price / Sales (TTM)
14.05
Price / Book
14.15
EV / EBITDA
-227.65
Profitability
Gross Margin
81.67%
Profit Margin
-30.68%
Operating Margin
-8.49%
Return on Assets
-5.17%
Return on Equity
-25.98%
Ownership
Shares Outstanding
58.85M
Float
56.82M
Held by Insiders
3.57%
Held by Institutions
105.41%
Price stats
Beta
0.69
50-Day Avg
148.36
200-Day Avg
117.73
Dividends
Payout Ratio
0.00%
Market Cap - 6GJ - Glaukos Corp.
Peers - 6GJ - Glaukos Corp.
Peer Comparison
Compared with companies in Medical Devices listed on FSX.
- 6GJFSXGlaukos Corp.8.61BMarket Cap+53.77%52-week change-44.51P/E (Trailing)-30.68%Profit Margin
- ABLFSXAbbott Laboratories162.02BMarket Cap-19.11%52-week change35.14P/E (Trailing)11.64%Profit Margin
- ABL0FSXAbbott Laboratories CDR153.08BMarket Cap-22.81%52-week change33.53P/E (Trailing)11.64%Profit Margin
- CFXFSXCapital One Financial Corp.107.66BMarket Cap-0.28%52-week change13.13P/E (Trailing)21.86%Profit Margin
- 2M6FSXMedtronic plc105.14BMarket Cap-1.02%52-week change22.97P/E (Trailing)13.93%Profit Margin
- SYKFSXStryker Corp.96.89BMarket Cap-25.65%52-week change29.85P/E (Trailing)14.43%Profit Margin
- ASGFSXAssicurazioni Generali S.p.A.64.17BMarket Cap+23.31%52-week change14.32P/E (Trailing)7.68%Profit Margin
Profile Summary - 6GJ - Glaukos Corp.
About
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for glaucoma, corneal disorders, and retinal diseases. Its product portfolio includes Micro-Invasive Glaucoma Surgery (MIGS) devices, sustained-release drug delivery systems, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
